DTRA glossary aims to promote adoption of decentralized format

By Jenni Spinner

- Last updated on GMT

(TarikVision/iStock via Getty Images Plus)
(TarikVision/iStock via Getty Images Plus)

Related tags Decentralized trials Decentralized Trials and Research Alliance Virtual clinical trials Patient centricity Clinical trials

The Decentralized Trials and Research Alliance is offering the research resource to increase awareness, understanding, and acceptance of the study format.

The Decentralized Trials & Research Alliance (DTRA) has announced the release of its DTRA Glossary, an informational resource emerging from cross-industry collaborative efforts aimed at promoting the global adoption of decentralized research. The glossary can be downloaded by anyone in the worldwide research community (and any other relevant stakeholders) at www.dtra.org​.

According to the organization, the glossary is intended to address two significant challenges:

  • a lack of consistent terminology for use within and between organizations
  • the need for a lexicon to describe different archetypes of decentralized research.

The glossary includes an interactive feedback collection tool to receive updates on existing terms while also identifying potential new terms.

The DTRA Glossary is reportedly the first output from DTRA’s 12 initiatives spanning four priorities as developed by the DTRA Leadership Council. The Glossary Team was co-led by Jared Klingeisen and Alison Poole with program management by Alexa Christensen. Information on the other initiatives can be found at www.dtra.org.

Amir Kalali, DTRA co-founder and co-chairman, said, “The release of the DTRA Glossary marks an important milestone in enabling understanding and uptake of methodologies that will improve access to research for patients. It is a testament of the collaboration of member organizations and will be where the whole community will look to for consistent terminology.”

Craig Lipset, co-founder and co-chairman of DTRA, said, “It is impossible to make progress when there is a Tower of Babel and we are not able to understand one another. This work builds up from the work of other important collaborations and projects, as referenced within the Glossary. This is just the first of a portfolio of new solutions coming forward from the DTRA initiative teams.”

Related news

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more